最新报道：According to Bijie.com, a leak allegedly from a former Swiss banker has fueled speculation about Ripple's ambitions beyond payments. If true, the confidentiality agreement suggests Ripple's infrastructure is more than just a remittance tool. Using the alias Lord Belgrave, the anonymous banker shared excerpts from a mutual confidentiality and strategic partnership agreement. It hints at the broader convergence of finance, digital identity, and compliance on the XRP Ledger (XRPL). A major Swiss bank and a US blockchain infrastructure company are involved. The purpose clause alone is noteworthy, mentioning biometric identity mapping. Other intriguing references include tokenized financial instruments and cross-border settlement via protocol-agnostic rails. A closer look reveals that terms like "neutral, protocol-agnostic mechanism" appear to refer to bridge assets like XRP. Meanwhile, references to "multi-layered liquidity corridors" suggest the integration of fiat currency rails, tokenized securities, and CBDCs within an interoperable framework. Perhaps most notable is the mention of biometric identity mapping, a feature rarely found in traditional banking protocols. This aligns with JPMorgan's recent statement on the foundations of Web3, which argues that digital identity is a prerequisite for financial integration. Ripple has already begun experimenting with healthcare payments through its XRP Ledger projects. For example, Wellgistics Health announced an XRPL-powered system to process transactions for 6,500 pharmacies in the United States. This, coupled with BlackRock's July 4th launch of the XDNA ETF, which some see as a symbolic step toward blockchain-based health finance, suggests the convergence of identity, finance, and healthcare. XRPL sits at the crossroads of politics and fundamentals. Timing also plays into a political narrative. US President Donald Trump has been pushing for digital healthcare reforms, and BlackRock's XDNA ETF launched on the same day his administration unveiled cost-cutting measures for the industry. Cryptocurrency commentators speculate that this is no coincidence, but rather a shift toward coordinated on-chain health data and payments. Meanwhile, Ripple's global expansion, through partnerships with Chipper Cash and Onafriq, and regional expansion in MENA, appears to be bolstering a "DNA protocol" that is quietly onboarding African laboratories and service providers. Critics suggest its goal may be to embed identity-linked settlement systems into global finance from a grassroots level. Meanwhile, supporters see this as proof that Ripple is laying the foundation for a neutral, institutional-grade settlement backbone. Elsewhere, fundamentals challenge XRPL's technical promise, suggesting it doesn't live up to the hype. Recent reports indicate a 38% drop in transaction counts, and despite a market valuation of $190 billion, the total value locked (TVL) is only $90 million. This contrast captures Ripple's crossroads. Is XRPL an underappreciated global backbone in the digital market, or a dangerous overestimation of unrealized potential? The XRPL team did not immediately respond to BeInCrypto’s request for comment.